栗佳男,张丽君,贺毅,吕树铮,宋现涛

• 1:首都医科大学附属北京安贞医院心内科

摘要(Abstract)：

<正>1冠状动脉慢性完全闭塞病变概述冠状动脉慢性闭塞病变(CTO)是指冠状动脉管腔完全闭塞且闭塞时间>3个月的病变~([1])。尽管新的治疗设备、器械以及技术的出现,对于CTO介入治疗的成功起到了重要作用~([2]),但CTO的经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)仍然是冠心病介入治疗领域的热点与难点。在PCI术前对CTO进行合理影像学评估,对术者采取更加

关键词(KeyWords)： 慢性完全闭塞病变;心脏磁共振成像;心肌活性

Abstract:

Keywords:

基金项目(Foundation): 基金项目:首都临床特色应用与成果推广(Z1611000005161139)

作者(Author): 栗佳男,张丽君,贺毅,吕树铮,宋现涛

参考文献(References)：

• [1]Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions.J Am Coll Cardiol,2011,58(24):e44-e122.
• [2]Rathore S,Matsuo H,Terashima M,et al.Procedural and inhospital outcomes after percutaneous coronary intervention for chronic total occlusions of coronary arteries 2002 to 2008:impact of novel guidewire techniques.JACC Cardiovasc Interv,2009,2(6):489-497.
• [3]Harold JG,Bass TA,Bashore TM,et al.ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures:a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians task force on clinical competence and training(writing committee to revise the 2007 clinical compe tence statement on cardiac interventional procedures).J Am Coll Cardiol,2013,62(4):357-396.
• [4]Glaveckaite S,Valeviciene N,Laucevicius A,et al.Cardiovascular magnetic resonanceimaging for detection of my ocardial viability in chronic ischemic left ventricular dysfunction.Medicina(kaunas),2009,45(8):585-599.
• [5]Allman KC.Noninvasive assessment myocardial viability:current status and future directions.J Nucl Cardiol,2013,20(4):618-637.
• [6]孙冬冬,王海昌.心肌存活的无创评估方法.中国介入心脏病学杂志,2014,22(11):724-726.
• [7]Kim RJ,Wu E,Rafael A,et al.The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.N Engl J Med,2000,343(20):1445-1453.
• [8]Kim RJ,Chen EL,Lima JA,et al.Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.Circulation,1996,94(12):3318-3326.
• [9]Kim RJ,Fieno DS,Parrish TB,et al.Relationship of MRI delayed contrast enhancement to irreversible injury,infarct age,and contractile function.Circulation,1999,100(19):1992-2002.
• [10]Klein C,Nekolla SG,Bengel FM,et al.Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging:comparison with positron emission tomography.Circulation,2002,105(2):162-167.
• [11]Knuesel PR,Nanz D,Wyss C,et al.Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance:Relation to functional outcome after revascularization.Circulation,2003,108(9):1095-1100.
• [12]Selvanayagam JB,Kardos A,Francis JM,et al.Value of delayed enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.Circulation,2004,110(12):1535-1541.
• [13]Gerber BL,Rousseau MF,Ahn SA,et al.Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction:impact of revascularization therapy.J Am Coll Cardiol,2012,59(9):825-835.
• [14]Bello D,Shah DJ,Farah GM,et al.Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.Circulation,2003,108(16):1945-1953.
• [15]Matsumoto H,Matsuda T,Miyamoto K,et al.Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction.JACC Cardiovasc Imaging,2011,4(6):610-618.
• [16]Baer FM,Theissen P,Schneider CA,et al.Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.J Am Coll Cardiol,1998,31(5):1040-1048.
• [17]Kirschbaum SW,Rossi A,Boersma E,et al.Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention.Int J Cardiol,2012,159(3):192-197.
• [18]Roes SD,Kaandorp TA,Marsan NA,et al.Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.Eur J Nucl Med Mol Imaging,2009,36(4):594-601.
• [19]Patterson RE,Sigman SR,O’Donnell RE,et al.Viability assessment with MRI is superior to FDG-PET for viability:Con.J Nucl Cardiol,2010,17(2):298-309.
• [20]Wellnhofer E,Olariu A,Klein C,et al.Magnetic resonance low dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery.Circulation,2004,109(18):2172-2174.
• [21]Cardona M,Martín V,Prat-Gonzalez S,et al.Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction:insights from a cardiovascular magnetic resonance study.J Cardiovasc Magn Reson,2016,18(1):78.
• [22]Ripley DP,Gosling OE,Bhatia L,et al.The relationship between the contralateral collateral supply and myocardial viability on cardiovascular magnetic resonance:can the angiogram predict functional recovery?Int J Cardiol,2014,177(2):362-367.
• [23]Pujadas S,Martin V,RossellóX,et al.Improvement of myocardial function and perfusion after successful percutaneous revascularization in patients with chronic total coronary occlusion.Int J Cardiol,2013,169(2):147-152.
• [24]Kirschbaum SW,Rossi A,Boersma E,et al.Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention.Int J Cardiol,2012,159(3):192-7.
• [25]Smith HJ.Cardiac MR imaging.Acta Radiol,1999,40(1):1-22.
• [26]Qayyum AA,Kastrup J.Measuring myocardial perfusion:the role of PET,MRI and CT.Clin Radiol,2015,70(6):576-584.